A real-world, retrospective study analysing efficacy and safety of nivolumab and ipilimumab combination therapy in patients with advanced melanoma
Latest Information Update: 02 Jun 2021
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Malignant melanoma; Skin cancer; Uveal melanoma
- Focus Adverse reactions; Therapeutic Use
- 02 Jun 2021 New trial record